nodes	percent_of_prediction	percent_of_DWPC	metapath
Paramethadione—CYP2C8—Paclitaxel—ovarian cancer	0.192	0.249	CbGbCtD
Paramethadione—CYP3A4—Topotecan—ovarian cancer	0.157	0.204	CbGbCtD
Paramethadione—CYP2C9—Paclitaxel—ovarian cancer	0.134	0.174	CbGbCtD
Paramethadione—CYP3A4—Vinorelbine—ovarian cancer	0.111	0.144	CbGbCtD
Paramethadione—CYP3A4—Paclitaxel—ovarian cancer	0.0778	0.101	CbGbCtD
Paramethadione—CYP3A4—Docetaxel—ovarian cancer	0.0562	0.0731	CbGbCtD
Paramethadione—CYP3A4—Doxorubicin—ovarian cancer	0.0419	0.0545	CbGbCtD
Paramethadione—CACNA1G—decidua—ovarian cancer	0.0122	0.128	CbGeAlD
Paramethadione—CACNA1I—testis—ovarian cancer	0.0113	0.118	CbGeAlD
Paramethadione—CACNA1H—myometrium—ovarian cancer	0.0107	0.113	CbGeAlD
Paramethadione—CACNA1I—lymph node—ovarian cancer	0.00816	0.0858	CbGeAlD
Paramethadione—CACNA1H—gonad—ovarian cancer	0.007	0.0736	CbGeAlD
Paramethadione—CACNA1H—uterus—ovarian cancer	0.00696	0.0732	CbGeAlD
Paramethadione—CACNA1H—female reproductive system—ovarian cancer	0.00625	0.0658	CbGeAlD
Paramethadione—CACNA1H—female gonad—ovarian cancer	0.00569	0.0598	CbGeAlD
Paramethadione—CACNA1H—testis—ovarian cancer	0.00505	0.0531	CbGeAlD
Paramethadione—CACNA1H—lymph node—ovarian cancer	0.00366	0.0385	CbGeAlD
Paramethadione—CYP2C8—endometrium—ovarian cancer	0.00314	0.033	CbGeAlD
Paramethadione—CYP2C8—female reproductive system—ovarian cancer	0.0026	0.0273	CbGeAlD
Paramethadione—CYP2C8—vagina—ovarian cancer	0.00235	0.0247	CbGeAlD
Paramethadione—CYP2C9—female reproductive system—ovarian cancer	0.00231	0.0243	CbGeAlD
Paramethadione—CYP2E1—female reproductive system—ovarian cancer	0.00219	0.023	CbGeAlD
Paramethadione—CYP2C8—testis—ovarian cancer	0.0021	0.022	CbGeAlD
Paramethadione—CYP2E1—testis—ovarian cancer	0.00176	0.0186	CbGeAlD
Paramethadione—CYP3A4—female reproductive system—ovarian cancer	0.00176	0.0185	CbGeAlD
Paramethadione—CACNA1H—Developmental Biology—NR5A1—ovarian cancer	0.00132	0.00977	CbGpPWpGaD
Paramethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—ovarian cancer	0.00131	0.00964	CbGpPWpGaD
Paramethadione—CACNA1I—NCAM signaling for neurite out-growth—MAPK3—ovarian cancer	0.00129	0.00951	CbGpPWpGaD
Paramethadione—CACNA1I—NCAM signaling for neurite out-growth—MAPK1—ovarian cancer	0.00123	0.00905	CbGpPWpGaD
Paramethadione—CACNA1I—NCAM signaling for neurite out-growth—KRAS—ovarian cancer	0.00116	0.00855	CbGpPWpGaD
Paramethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—ovarian cancer	0.00109	0.00801	CbGpPWpGaD
Paramethadione—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.00105	0.00778	CbGpPWpGaD
Paramethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—ovarian cancer	0.00101	0.00747	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—HNF1B—ovarian cancer	0.00101	0.00744	CbGpPWpGaD
Paramethadione—CYP2E1—Tryptophan metabolism—CYP1B1—ovarian cancer	0.00101	0.00742	CbGpPWpGaD
Paramethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—ovarian cancer	0.001	0.00739	CbGpPWpGaD
Paramethadione—CACNA1G—NCAM signaling for neurite out-growth—NRAS—ovarian cancer	0.000992	0.00732	CbGpPWpGaD
Paramethadione—CYP3A4—Estrogen metabolism—CYP1B1—ovarian cancer	0.000988	0.00729	CbGpPWpGaD
Paramethadione—CACNA1I—NCAM signaling for neurite out-growth—HRAS—ovarian cancer	0.000984	0.00727	CbGpPWpGaD
Paramethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—ovarian cancer	0.000982	0.00725	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—HNF1B—ovarian cancer	0.000976	0.00721	CbGpPWpGaD
Paramethadione—CACNA1H—NCAM signaling for neurite out-growth—NRAS—ovarian cancer	0.000961	0.00709	CbGpPWpGaD
Paramethadione—CACNA1G—NCAM signaling for neurite out-growth—MAPK3—ovarian cancer	0.00095	0.00701	CbGpPWpGaD
Paramethadione—CACNA1I—NCAM signaling for neurite out-growth—IL6—ovarian cancer	0.000942	0.00695	CbGpPWpGaD
Paramethadione—CACNA1H—Corticotropin-releasing hormone—CXCL8—ovarian cancer	0.00094	0.00694	CbGpPWpGaD
Paramethadione—CACNA1H—NCAM signaling for neurite out-growth—MAPK3—ovarian cancer	0.00092	0.00679	CbGpPWpGaD
Paramethadione—CACNA1G—NCAM signaling for neurite out-growth—MAPK1—ovarian cancer	0.000904	0.00667	CbGpPWpGaD
Paramethadione—CACNA1H—Corticotropin-releasing hormone—CASP3—ovarian cancer	0.0009	0.00664	CbGpPWpGaD
Paramethadione—CACNA1H—Corticotropin-releasing hormone—IL2—ovarian cancer	0.000899	0.00663	CbGpPWpGaD
Paramethadione—CACNA1H—NCAM signaling for neurite out-growth—MAPK1—ovarian cancer	0.000876	0.00646	CbGpPWpGaD
Paramethadione—CYP3A4—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.000874	0.00645	CbGpPWpGaD
Paramethadione—CACNA1H—Corticotropin-releasing hormone—CTNNB1—ovarian cancer	0.000868	0.0064	CbGpPWpGaD
Paramethadione—CACNA1G—NCAM signaling for neurite out-growth—KRAS—ovarian cancer	0.000854	0.0063	CbGpPWpGaD
Paramethadione—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ovarian cancer	0.000852	0.00629	CbGpPWpGaD
Paramethadione—CACNA1H—NCAM signaling for neurite out-growth—KRAS—ovarian cancer	0.000827	0.0061	CbGpPWpGaD
Paramethadione—CYP2C8—Arachidonic acid metabolism—CYP1B1—ovarian cancer	0.000813	0.006	CbGpPWpGaD
Paramethadione—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000813	0.006	CbGpPWpGaD
Paramethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—ovarian cancer	0.000811	0.00599	CbGpPWpGaD
Paramethadione—CYP2E1—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000803	0.00592	CbGpPWpGaD
Paramethadione—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.000779	0.00575	CbGpPWpGaD
Paramethadione—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.000742	0.00548	CbGpPWpGaD
Paramethadione—CACNA1G—NCAM signaling for neurite out-growth—HRAS—ovarian cancer	0.000726	0.00536	CbGpPWpGaD
Paramethadione—CACNA1H—Corticotropin-releasing hormone—MAPK3—ovarian cancer	0.000723	0.00533	CbGpPWpGaD
Paramethadione—CYP3A4—Irinotecan Pathway—APC—ovarian cancer	0.000717	0.00529	CbGpPWpGaD
Paramethadione—CACNA1H—NCAM signaling for neurite out-growth—HRAS—ovarian cancer	0.000703	0.00519	CbGpPWpGaD
Paramethadione—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000703	0.00519	CbGpPWpGaD
Paramethadione—CACNA1G—NCAM signaling for neurite out-growth—IL6—ovarian cancer	0.000695	0.00513	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—MET—ovarian cancer	0.000694	0.00512	CbGpPWpGaD
Paramethadione—CYP2C8—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000694	0.00512	CbGpPWpGaD
Paramethadione—CACNA1H—Corticotropin-releasing hormone—MAPK1—ovarian cancer	0.000687	0.00507	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—IL6ST—ovarian cancer	0.00068	0.00502	CbGpPWpGaD
Paramethadione—CACNA1H—NCAM signaling for neurite out-growth—IL6—ovarian cancer	0.000673	0.00496	CbGpPWpGaD
Paramethadione—CYP2C9—Arachidonic acid metabolism—CYP1B1—ovarian cancer	0.000662	0.00488	CbGpPWpGaD
Paramethadione—CYP2E1—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000659	0.00486	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—MMP2—ovarian cancer	0.000579	0.00427	CbGpPWpGaD
Paramethadione—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000572	0.00422	CbGpPWpGaD
Paramethadione—CYP2C8—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.00057	0.00421	CbGpPWpGaD
Paramethadione—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000565	0.00417	CbGpPWpGaD
Paramethadione—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.000514	0.00379	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—MET—ovarian cancer	0.000512	0.00378	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—ERBB2—ovarian cancer	0.000507	0.00374	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—IL6ST—ovarian cancer	0.000501	0.0037	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—MET—ovarian cancer	0.000496	0.00366	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—MET—ovarian cancer	0.000495	0.00365	CbGpPWpGaD
Paramethadione—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.000489	0.00361	CbGpPWpGaD
Paramethadione—CACNA1H—Corticotropin-releasing hormone—AKT1—ovarian cancer	0.000487	0.0036	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—IL6ST—ovarian cancer	0.000485	0.00358	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—IL6ST—ovarian cancer	0.000485	0.00358	CbGpPWpGaD
Paramethadione—CYP3A4—Tryptophan metabolism—CYP1B1—ovarian cancer	0.000467	0.00344	CbGpPWpGaD
Paramethadione—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000464	0.00342	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—MMP9—ovarian cancer	0.000435	0.00321	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—MMP2—ovarian cancer	0.000427	0.00315	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—MMP2—ovarian cancer	0.000413	0.00305	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—MMP2—ovarian cancer	0.000413	0.00305	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—VEGFA—ovarian cancer	0.000391	0.00288	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—NRAS—ovarian cancer	0.000386	0.00285	CbGpPWpGaD
Paramethadione—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000377	0.00278	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—ERBB2—ovarian cancer	0.000374	0.00276	CbGpPWpGaD
Paramethadione—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000372	0.00275	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—MAPK3—ovarian cancer	0.00037	0.00273	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—MET—ovarian cancer	0.000365	0.00269	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—ERBB2—ovarian cancer	0.000362	0.00267	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—ERBB2—ovarian cancer	0.000362	0.00267	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—IL6ST—ovarian cancer	0.000358	0.00264	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—MET—ovarian cancer	0.000354	0.00261	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—MAPK1—ovarian cancer	0.000352	0.0026	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—EGFR—ovarian cancer	0.000352	0.00259	CbGpPWpGaD
Paramethadione—CYP2E1—Biological oxidations—CYP1B1—ovarian cancer	0.00035	0.00258	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—IL6ST—ovarian cancer	0.000346	0.00256	CbGpPWpGaD
Paramethadione—CYP2E1—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000345	0.00255	CbGpPWpGaD
Paramethadione—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—ovarian cancer	0.000339	0.0025	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—KRAS—ovarian cancer	0.000332	0.00245	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—MMP9—ovarian cancer	0.000321	0.00237	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—CTNNB1—ovarian cancer	0.000317	0.00234	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—MMP9—ovarian cancer	0.000311	0.00229	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—MMP9—ovarian cancer	0.000311	0.00229	CbGpPWpGaD
Paramethadione—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000306	0.00226	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—MMP2—ovarian cancer	0.000305	0.00225	CbGpPWpGaD
Paramethadione—CYP2C8—Biological oxidations—CYP1B1—ovarian cancer	0.000303	0.00223	CbGpPWpGaD
Paramethadione—CYP2C8—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000299	0.0022	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—MMP2—ovarian cancer	0.000295	0.00218	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—VEGFA—ovarian cancer	0.000288	0.00213	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—NRAS—ovarian cancer	0.000285	0.0021	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—HRAS—ovarian cancer	0.000282	0.00208	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—VEGFA—ovarian cancer	0.000279	0.00206	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—VEGFA—ovarian cancer	0.000279	0.00206	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—STAT3—ovarian cancer	0.000276	0.00204	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—NRAS—ovarian cancer	0.000276	0.00203	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—NRAS—ovarian cancer	0.000275	0.00203	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—MAPK3—ovarian cancer	0.000272	0.00201	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—IL6—ovarian cancer	0.00027	0.00199	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—ERBB2—ovarian cancer	0.000267	0.00197	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—MAPK3—ovarian cancer	0.000264	0.00195	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—MAPK3—ovarian cancer	0.000264	0.00195	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—MAPK1—ovarian cancer	0.000259	0.00191	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—EGFR—ovarian cancer	0.000259	0.00191	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—ERBB2—ovarian cancer	0.000258	0.00191	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—MAPK1—ovarian cancer	0.000251	0.00185	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—EGFR—ovarian cancer	0.000251	0.00185	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—MAPK1—ovarian cancer	0.000251	0.00185	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—EGFR—ovarian cancer	0.000251	0.00185	CbGpPWpGaD
Paramethadione—CYP2C9—Biological oxidations—CYP1B1—ovarian cancer	0.000246	0.00182	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—KRAS—ovarian cancer	0.000245	0.00181	CbGpPWpGaD
Paramethadione—CYP2C9—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000243	0.00179	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—KRAS—ovarian cancer	0.000237	0.00175	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—KRAS—ovarian cancer	0.000237	0.00175	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—CTNNB1—ovarian cancer	0.000233	0.00172	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000233	0.00172	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—MMP9—ovarian cancer	0.000229	0.00169	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—CTNNB1—ovarian cancer	0.000226	0.00167	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—MMP9—ovarian cancer	0.000222	0.00164	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—NME2—ovarian cancer	0.000214	0.00158	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—HRAS—ovarian cancer	0.000208	0.00154	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—VEGFA—ovarian cancer	0.000206	0.00152	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—STAT3—ovarian cancer	0.000204	0.0015	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—NRAS—ovarian cancer	0.000203	0.0015	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—HRAS—ovarian cancer	0.000202	0.00149	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—HRAS—ovarian cancer	0.000201	0.00149	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—IL6—ovarian cancer	0.000199	0.00147	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—VEGFA—ovarian cancer	0.000199	0.00147	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—STAT3—ovarian cancer	0.000197	0.00145	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—NRAS—ovarian cancer	0.000197	0.00145	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—MAPK3—ovarian cancer	0.000194	0.00144	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—IL6—ovarian cancer	0.000193	0.00142	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—IL6—ovarian cancer	0.000193	0.00142	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.00019	0.0014	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—MAPK3—ovarian cancer	0.000188	0.00139	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—MAPK1—ovarian cancer	0.000185	0.00137	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—EGFR—ovarian cancer	0.000185	0.00137	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—NME2—ovarian cancer	0.000185	0.00136	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—MAPK1—ovarian cancer	0.000179	0.00132	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—EGFR—ovarian cancer	0.000179	0.00132	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—AKT1—ovarian cancer	0.000178	0.00131	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—KRAS—ovarian cancer	0.000175	0.00129	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—KRAS—ovarian cancer	0.000169	0.00125	CbGpPWpGaD
Paramethadione—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	0.000162	0.0012	CbGpPWpGaD
Paramethadione—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	0.00016	0.00118	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000157	0.00116	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—NME2—ovarian cancer	0.00015	0.00111	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—HRAS—ovarian cancer	0.000149	0.0011	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—HRAS—ovarian cancer	0.000144	0.00106	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—IL6—ovarian cancer	0.000142	0.00105	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—IL6—ovarian cancer	0.000138	0.00102	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—CYTB—ovarian cancer	0.000138	0.00102	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—AKT1—ovarian cancer	0.000131	0.000968	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000128	0.000942	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000127	0.00094	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—AKT1—ovarian cancer	0.000127	0.000937	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—PPP1CC—ovarian cancer	0.00012	0.000887	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—BRIP1—ovarian cancer	0.00012	0.000887	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—CYTB—ovarian cancer	0.000119	0.000878	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000116	0.000858	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—BRIP1—ovarian cancer	0.000104	0.000767	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—PPP1CC—ovarian cancer	0.000104	0.000767	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000104	0.000766	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—NME2—ovarian cancer	9.91e-05	0.000731	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—CYTB—ovarian cancer	9.68e-05	0.000714	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	9.46e-05	0.000698	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—PPP1CC—ovarian cancer	8.46e-05	0.000624	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—BRIP1—ovarian cancer	8.46e-05	0.000624	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—YAP1—ovarian cancer	8.07e-05	0.000595	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	7.57e-05	0.000559	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—YAP1—ovarian cancer	6.97e-05	0.000514	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	6.9e-05	0.000509	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—FASN—ovarian cancer	6.58e-05	0.000485	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—SLC5A5—ovarian cancer	6.47e-05	0.000477	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—CYTB—ovarian cancer	6.38e-05	0.000471	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—SLC2A1—ovarian cancer	6.25e-05	0.000461	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	6.16e-05	0.000455	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	6.07e-05	0.000448	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—CYP1B1—ovarian cancer	5.99e-05	0.000442	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—FASN—ovarian cancer	5.68e-05	0.000419	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—YAP1—ovarian cancer	5.67e-05	0.000419	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	5.62e-05	0.000414	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—SLC5A5—ovarian cancer	5.59e-05	0.000413	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—BRIP1—ovarian cancer	5.58e-05	0.000412	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—PPP1CC—ovarian cancer	5.58e-05	0.000412	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—SLC2A1—ovarian cancer	5.4e-05	0.000398	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	5.31e-05	0.000392	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	5.29e-05	0.00039	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—CYP1B1—ovarian cancer	5.18e-05	0.000382	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.94e-05	0.000364	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—ABCB1—ovarian cancer	4.93e-05	0.000364	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—TYMS—ovarian cancer	4.84e-05	0.000357	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—FASN—ovarian cancer	4.63e-05	0.000341	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	4.59e-05	0.000339	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.57e-05	0.000337	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—SLC5A5—ovarian cancer	4.55e-05	0.000336	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—SLC2A1—ovarian cancer	4.39e-05	0.000324	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.3e-05	0.000318	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—ABCB1—ovarian cancer	4.26e-05	0.000315	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—CYP1B1—ovarian cancer	4.21e-05	0.000311	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—TYMS—ovarian cancer	4.19e-05	0.000309	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—CAV1—ovarian cancer	3.9e-05	0.000288	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—YAP1—ovarian cancer	3.74e-05	0.000276	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	3.74e-05	0.000276	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.72e-05	0.000274	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—PIK3CG—ovarian cancer	3.55e-05	0.000262	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—ABCB1—ovarian cancer	3.47e-05	0.000256	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—TYMS—ovarian cancer	3.41e-05	0.000251	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—CAV1—ovarian cancer	3.37e-05	0.000249	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.22e-05	0.000238	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—PIK3CD—ovarian cancer	3.13e-05	0.000231	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—PIK3CG—ovarian cancer	3.07e-05	0.000227	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—FASN—ovarian cancer	3.05e-05	0.000225	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—SLC5A5—ovarian cancer	3e-05	0.000221	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—SLC2A1—ovarian cancer	2.9e-05	0.000214	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—CYP1B1—ovarian cancer	2.78e-05	0.000205	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—CAV1—ovarian cancer	2.75e-05	0.000203	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—PIK3CB—ovarian cancer	2.72e-05	0.000201	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—PIK3CD—ovarian cancer	2.7e-05	0.000199	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.62e-05	0.000194	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—PIK3CG—ovarian cancer	2.5e-05	0.000185	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	2.46e-05	0.000182	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—PIK3CB—ovarian cancer	2.35e-05	0.000174	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—PTEN—ovarian cancer	2.35e-05	0.000174	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—ABCB1—ovarian cancer	2.29e-05	0.000169	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—TYMS—ovarian cancer	2.25e-05	0.000166	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—PIK3CD—ovarian cancer	2.2e-05	0.000162	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—PTEN—ovarian cancer	2.03e-05	0.00015	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—PIK3CB—ovarian cancer	1.92e-05	0.000141	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—CAV1—ovarian cancer	1.81e-05	0.000134	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—PIK3CA—ovarian cancer	1.66e-05	0.000123	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—PTEN—ovarian cancer	1.66e-05	0.000122	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.65e-05	0.000122	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.45e-05	0.000107	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—PIK3CA—ovarian cancer	1.44e-05	0.000106	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—AKT1—ovarian cancer	1.36e-05	0.0001	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.26e-05	9.33e-05	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—AKT1—ovarian cancer	1.17e-05	8.65e-05	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.17e-05	8.62e-05	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—PTEN—ovarian cancer	1.09e-05	8.06e-05	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—AKT1—ovarian cancer	9.54e-06	7.04e-05	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—PIK3CA—ovarian cancer	7.7e-06	5.69e-05	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—AKT1—ovarian cancer	6.29e-06	4.64e-05	CbGpPWpGaD
